Your browser doesn't support javascript.
loading
Increased risks of SARS-CoV-2 nosocomial acquisition in high-risk COVID-19 units justify personal protective equipment: a cross-sectional study.
Bistoquet, M; Galtier, F; Marin, G; Villard, O; Ferreira, R; Hermabessiere, S; Montoya, A; Jumas-Bilak, E; Pageaux, G-P; Dereure, O; Chanques, G; Klouche, K; Morquin, D; Reynes, J; Le Moing, V; Picot, M-C; Tuaillon, E; Makinson, A.
Afiliación
  • Bistoquet M; Infectious Diseases Departement, University Hospital Montpellier, Montpellier, France.
  • Galtier F; Clinical Investigation Centre (CIC), Inserm 1411, University Hospital of Montpellier, Montpellier, France.
  • Marin G; Department of Epidemiology, Medical Statistics and Public Health, University Hospital of Montpellier, Montpellier, France.
  • Villard O; Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, Montpellier, France; Institute of Functional Genomics, CNRS, INSERM, University of Montpellier, Montpellier, France.
  • Ferreira R; Clinical Department for Osteoarticular Diseases and Biotherapy, University Hospital Montpellier, Montpellier, France.
  • Hermabessiere S; Infectious Diseases Departement, University Hospital Montpellier, Montpellier, France.
  • Montoya A; Infectious Diseases Departement, University Hospital Montpellier, Montpellier, France.
  • Jumas-Bilak E; Hygiene Department, University Hospital Montpellier, Montpellier, France.
  • Pageaux GP; Department of Hepatology and Liver Transplantation,University Hospital Montpellier, Montpellier, France.
  • Dereure O; Department of Dermatology, University Hospital of Montpellier, Montpellier, France.
  • Chanques G; Department of Anaesthesia & Critical Care Medicine, Montpellier University Hospital, Montpellier, France; PhyMedExp, University of Montpellier, INSERM, CNRS, Montpellier, France.
  • Klouche K; Intensive Care Unit, Univesity Hospital Montpellier, Montpellier, France.
  • Morquin D; Infectious Diseases Departement, University Hospital Montpellier, Montpellier, France.
  • Reynes J; Infectious Diseases Departement, University Hospital Montpellier, Montpellier, France; INSERM U1175/Institut de Recherche et de Developement, Unité Mixte International, Montpellier, France.
  • Le Moing V; Infectious Diseases Departement, University Hospital Montpellier, Montpellier, France; INSERM U1175/Institut de Recherche et de Developement, Unité Mixte International, Montpellier, France.
  • Picot MC; Department of Epidemiology, Medical Statistics and Public Health, University Hospital of Montpellier, Montpellier, France.
  • Tuaillon E; Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, Etablissement Français du Sang, Montpellier, France.
  • Makinson A; Infectious Diseases Departement, University Hospital Montpellier, Montpellier, France; INSERM U1175/Institut de Recherche et de Developement, Unité Mixte International, Montpellier, France. Electronic address: a-makinson@chu-montpellier.fr.
J Hosp Infect ; 107: 108-110, 2021 01.
Article en En | MEDLINE | ID: mdl-33137443

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infección Hospitalaria / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Hosp Infect Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infección Hospitalaria / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Hosp Infect Año: 2021 Tipo del documento: Article País de afiliación: Francia